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Abstract: Surfactants, such as glycolipids, are specialty compounds that can be encountered daily
in cleaning agents, pharmaceuticals or even in food. Due to their wide range of applications and,
more notably, their presence in hygiene products, the demand is continuously increasing worldwide.
The established chemical synthesis of glycolipids presents several disadvantages, such as lack of
specificity and selectivity. Moreover, the solubility of polyols, such as sugars or sugar alcohols, in
organic solvents is rather low. The enzymatic synthesis of these compounds is, however, possible
in nearly water-free media using inexpensive and renewable building blocks. Using lipases, ester
formation can be achieved under mild conditions. We propose, herein, a “2-in-1” system that
overcomes solubility problems, as a Deep Eutectic System (DES) made of sorbitol and choline chloride
replaces either a purely organic or aqueous medium. For the first time, 16 commercially available
lipase formulations were compared, and the factors affecting the conversion were investigated to
optimize this process, owing to a newly developed High-Performance Liquid Chromatography-
Evaporative Light Scattering Detector (HPLC-ELSD) method for quantification. Thus, using 50 g/L
of lipase formulation Novozym 435® at 50 ◦C, the optimized synthesis of sorbitol laurate (SL) allowed
to achieve 28% molar conversion of 0.5 M of vinyl laurate to its sugar alcohol monoester when the
DES contained 5 wt.% water. After 48h, the de novo synthesized glycolipid was separated from the
media by liquid–liquid extraction, purified by flash-chromatography and characterized thoroughly
by one- and two-dimensional Nuclear Magnetic Resonance (NMR) experiments combined to Mass
Spectrometry (MS). In completion, we provide initial proof of scalability for this process. Using
a 2.5 L stirred tank reactor (STR) allowed a batch production reaching 25 g/L in a highly viscous
two-phase system.
Keywords: glycolipid; sugar alcohol; ester; biosynthesis; optimization; unconventional media
1. Introduction
Glycolipids and, more generally, surfactants are getting more attention and are cur-
rently under scrutiny from the scientific community because of their various fields of
applications [1]. This versatility allows them to fill different functions, such as excipient
in drugs, encapsulating agents, lubricants and many more [2]. Such quasi-omnipresence
makes their use valuable in very concrete and industrialized applications such as oil recov-
ery enhancement or even as dough conditioning [3,4]. Moreover, the recent sanitary crisis,
which resulted from the current global pandemic, is announced to increase further this
production, as surfactants are among the main components present in hygiene products [5].
Thus, the whole chain of production starting from the acquisition of raw materials to
Molecules 2021, 26, 2759. https://doi.org/10.3390/molecules26092759 https://www.mdpi.com/journal/molecules
Molecules 2021, 26, 2759 2 of 19
the formulation and storage should be logically stimulated as well. Given the context, it
appears topical to develop processes that enable safe, reliable and straightforward produc-
tion of such compounds. In addition, the processes and the resulting compounds should
respond to present concerns in relation to sustainability, renewability, and biodegradability.
Such problems brought to awareness and theorized by the Green Chemistry field revolve
around the “benign by design” concept [6]. By definition, it means that chemical products
and processes should be designed to eliminate the generation of hazardous substances [7].
Therefore, it reduces the number of steps necessary for the production, from the synthesis
to the downstream processing (DSP), and simplifies the overall process chain.
Glycolipids, such as sugar esters (SEs), are, in this regard, relevant candidates that
meet the aforementioned requirements; several challenges and problems are raising in the
meantime, which are tackled in this work.
The well-established chemical production of SEs presents several disadvantages and
limitations such as low specificity, low selectivity and use of corrosive reactants [8]. Con-
sequently, alternative ways were pursued to prevent the use of organic solvents, as they
represent most of the waste in industrial processes and syntheses [9]. Moreover, they
present undeniable limitations for the solubilization of polyols such as sugars. In this aim,
the production of SEs in ionic liquids (ILs) [10] and in Deep Eutectic Systems (DESs) [11]
were investigated. The latter, described first by Abbott et al., represents a cheaper, less
toxic, and facile option among the low-transition temperature mixtures [12]. Additionally,
their low water contents and low water activities lead lipases to reverse their activity and
form ester bonds using relatively mild and harmless conditions [13].
Numerous applications of DESs in environmentally friendly chemical processes have
been made, notably for the production of pharmaceutically relevant building blocks and
scaffolds [14–16]. Moreover, DESs can also be used for the extraction of valuable com-
pounds such as phenolics contained in olive oil wastes [17], adding them as a sustainable
tool for food waste treatment and re-valorization. In our similar and inherently benign
approach, sorbitol is simultaneously part of the solvent as a DES partner, in combination
with choline chloride, and part of the lipase-catalyzed reaction as a substrate. Intrinsically,
this reaction design solves solubility problems of the polyols while saturating the system
with the acyl acceptor. This “2-in-1” principle described first by Siebenhaller et al. [18],
using notably C4 to C6 sugars in combination with vinyl fatty esters, presented however
exceptionally low yields (~4%) and lacked proof of scalability [19]. The use of vinyl esters
for SE synthesis, described by Bornscheuer et al., is thermodynamically favored as the
vinyl adduct is converted during the reaction to the side-product ethenol, which itself
tautomerizes in the highly volatile acetaldehyde [20] (Figure 1). For the first time, we en-
hanced further the conversion yield of this advantageous system, using a relatively better
acyl acceptor for the reaction [21]. Indeed, sorbitol and, more generally sugar alcohols,
showed successful use in prior research as they are also less sensitive to degradation than
their actual sugar analogues [22–25]. Moreover, laurate monoesters are valuable for many
recently developed applications such as drug encapsulation [26].
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Figure 1. Lipase-catalyzed transesterification reaction between D-sorbitol and vinyl laurate. Evaporation of highly volatile
acetaldehyde makes the conversion irreversible. S: Sorbitol; CC: Choline Chloride; mR: molar Ratio.
We initiated, herein, the optimization of the “2-in-1” process by selecting Novozym
435® as a suitable biocatalyst among various commercially available lipase formulations
and sought, specifically to our system, its optimal performing parameters. We varied
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parameters (One-Factor-at-a-Time, OFaaT) one at a time, such as biocatalyst concentration,
time of reaction, substrate concentration and water content. The optimal temperature for
the use of this specific lipase has been extensively studied in literature. Moreover, previous
work from Siebenhaller et al. [27] and Hollenbach et al. [28] presented concomitantly that
in the range of 50–60 ◦C, the enzyme meets its optimal activation energy.
In addition, we present robust purification and identification strategies promoted
by suitable analytical but also flash-chromatography methods for the quantification and
preparative scale (>500 g) production of sorbitol-6-O-laurate using a batch stirred tank
reactor (STR). The successful investigation was insured by the use of relevant Evaporative
Light Scattering Detection (ELSD) combined with HPLC and flash-chromatography. Thus,
the production of pure standards enabled the establishment of the calibration curve and the
1D-, 2D-Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) characterization
of selectively-acylated sorbitol monolaurate.
2. Results
In the following sections, we report the investigation of commercially available lipase
formulations to produce SL alongside a newly developed quantification method that
allowed the investigation of the impact of several synthesis factors. Following the product
formation over time also allowed optimization of reaction time, enzyme and substrate
concentration and subsequently, the water content of the DES. Finally, the titer of the
optimized process, as well as proof of scalability and technical notes for the use of a batch
STR followed by the DSP procedure, are presented.
2.1. Sorbitol Monolaurate (SL) Quantification
We, herein, successfully separated and quantified SL using a newly developed analyti-
cal HPLC-ESLD method, which allowed the differentiation of the products and substrates
(Supplementary Materials Figure S1). Sorbitol had a retention time of 2.1 min, 3.1 min for
SL and ~9.5 min for lauric acid (not integrated). Due to the low baseline noise and suitable
peak resolution (Table 1), it was possible to quantify SL in a range between 0.75 g/L and
30 g/L with the use of two linear ranges of calibration as ELSD does not provide a linear
response when analyte concentration increased.
Table 1. Chromatographic and analytical characteristics of SL analysis using HPLC-ESLD.
Retention time (SL) * 3.55–3.59 min
Peak width ** 0.060–0.091 min
Resolutionsorbitol—SL (n = 3) 17.5
ResolutionSL—lauric acid (n = 3) 7.6
Baseline noise (n =3) 0.22 ± 0.07 mV
Limit of detection (signal/noise = 3) <0.04 g/L
Limit of quantification (signal/noise = 10) 0.04 g/L
1st Range of Linear Calibration
Correlation coefficient (R2, n = 3) 0.9967
Equation of linear calibration y = 0.001x + 0.988
Linear range of calibration 0.75–15 g/L
2nd Range of Linear Calibration
Correlation coefficient (R2, n = 3) 0.9993
Equation of linear calibration y = 0.002x − 21.639
Linear range of calibration 20–30 g/L
* Inter-day variance of retention time measured at 3 different days. ** Concentration 0.75–30 g/L.
2.2. Commercially Available Formulations Screening
Figure 2 shows that the highest yields of vinyl laurate conversion into SL were ob-
tained by Lipase B from Candida antarctica (CA) formulations such as Novozym 435®,
Lipozyme 435® and Lipozyme CALB L (liquid formulation). Regardless of the applied
form, all of them seem to reach statistically equivalent results of ~20% under non-optimized
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reaction conditions. However, it is important to note that liquid formulations potentially
contain more catalytic material than the immobilized ones, showing the limitations of
our comparison.
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r little data on the matter are made available by the producers. Howev r, the quantity of
enzyme is directly linked to the amount f formulation used; thus, w en comparing immo-
bilized en ymes, this variable is intrinsically highlighted. As a result, we are, among other
factors, comparing qualitatively the immobilization efficiency of the various formul ti ns
tested. In this aim and i our system, either using the food-grade formulation (Lipozyme
435®) or the technical grade one (Novozym 435®) did not lead to significant differences
in titer after 48 h of reaction (Table 2). Interestingly the Cross-Linked Enzyme Aggregate
(CLEA) from CA seemed to reach statistically similar levels of performance. Therefore,
in the following sections, we chose to report the influence of several factors affecting our
system. For this purpose, we used Novozym 435® as the archetype of the commercially
available lipase formulation for SE synthesis. As a first step, we decided to investigate the
evolution of SL titer over time.
2.3. Product Formation over Time
To determine the optimal reaction time to produce the maximum amount of SL, the
concentration of produced glycolipid was recorded over 96 h. Thus, we reached a saturation
of product after 48 h with apparently no significant changes in concentration, even up to
96 h of reaction, as shown in Figure 3.
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Table 2. Titer (g/L) of SL obtained after 48 h with commercially available enzyme formulations.
Formulation Name Reported Activity * Formulation Type Reported OptimalTemperature Range (◦C) * Titer (g/L) **
CalA Immo 150 500 U/g Immobilized N.C. 2.3 ± 0.9
CalB Immo Plus >9000 PLU/g Immobilized 60–80 13.3 ± 3.0
Lipase CA CLEA >1.5 U/mg Cross-linked >40 38.2 ± 3.8
Lipase TL CLEA ≥25 U/mg Cross-linked 40–60 9.2 ± 2.7
Lipozym 435 9000 PLU/g Immobilized N.C. 38.2 ± 3.8
Lipozyme CALB L 5000 LU/g Liquid 30–60 38.2 ± 3.8
Lipozyme RM IM 275 IUN/g Immobilized 30–50 13.2 ± 2.7
Lipozyme TL 100L 100 KLU/g Liquid 20–50 3.3 ± 1.2
Lipozyme TL IM 250 IUN/g Immobilized 50–75 1.3 ± 1.0
NovoCor AD L 6000 LU/g Liquid 30–60 3.3 ± 1.2
Novozym 40086 275 IUN/g Immobilized 30–50 2.2 ± 1.1
Novozym 435 10,000 PLU/g Immobilized 30–60 38.2 ± 3.8
Novozym 51032 15 KLU/g Liquid 35–70 4.4 ± 1.3
Novozym NS 81356 N.C. Immobilized N.C. 10.6 ± 1.4
Palatase 20000 L 20,000 LU/g Liquid 30–50 10.0 ± 2.1
Resinase HT 50 KLU/g Liquid ≤90 7.3 ± 1.3
N.C.: Not Communicated. * Reported data are provided by the producers and are available online. ** Experiments were performed as
triplicates under identical conditions: 0.5 M of vinyl laurate and 20 mg of formulation in 1.5 mL of Sorbit DES (sorbitol/choline chloride,
1:1, mR, 5 wt.% water) after 48h at 50 ◦C. Data is presented as mean values ± standard deviations (n = 3, p-value < 0.05).
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Figure 3. Ti e course of the reaction under unopti ized conditions: 0.5 of vinyl laurate, 20 g
of Novozym 435® and 1.5 mL of Sorbit DES as solvent (sorbitol/choline chloride, 1:1, mR, 5 wt.%
water) at 50 ◦C.
nder these unoptimized conditions using Novozym 435®, a concentration of 95 ± 2.5 mM
of the product was obtained after 48 h of reaction, which translates to specific productivity
of 100 µmol/h/g. Until now, no data has been reported regarding the use of a “2-in-1” DES
system for lipase-catalyzed transesterification between a vinyl laurate and sorbitol in order
to synthetize such mo oacylated sugar alcohol ester.
2.4. Effect of Enzyme, Substrate and Water Contents
Herein, Novozym 435® was used as the biocatalyst for the reaction that was carried
out in the “2-in-1” Sorbit DES. Factors impacting the reaction (i.e., enzyme concentration,
enzyme dosage and water content in the media) have been investigated to find the optimal
parameters for each condition. From Figure 4, it can be discerned that the optimal values
were 50 g/L enzyme, 0.5 M vinyl laurate and 5 wt.% water.
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Figure 4. Novozym 435®-catalyzed transesterification of sorbitol and vinyl laurate in “2-in-1” Sorbit
deep eutectic system: Effect of enzyme dosage (A); vinyl laurate concentration (B); water content in
the media (C) on the titer after 48 h. a–d show statistically significant differences, at a 0.05 significance
level, of the mean values obtained from three independent experiments ran under each condition.
Statistical analysis of the different titers reached after 48 h in relation to enzyme
concentration revealed significant differences when the amount of enzyme was at least
doubled from the 20 g/L starting point (Figure 4A). Drastic differences can be observed
in Figure 4B, as 0.5 M of vinyl laurate induces a two-fold increase in titer compared to
0.25 M and 0.75 M. This safely suggests that upon a range of concentration > 0.5 M, there
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was potentially an inhibition of the biocatalyst due to substrate saturation. Above this
concentration and in spite of the statistical analysis, comparisons are rendered ambiguous
considering the lack of trend and should be interpreted with a certain distance. The
results displayed in Figure 4C are rather more ambiguous as well, concerning the water
content. Indeed, above 5 wt.% water, it seems that an optimal range of water content was
reached. Overall, the results tend to indicate that enzyme and substrate concentrations
were predominant factors compared to the water content, to some extent, as the Sorbit DES
with a 2.5 wt.% water content ultimately limits the conversion most probably due to its
measured 2-fold higher viscosity (Table A1). It also seems that the Sorbit DES with 5 wt.%
water provides the optimal Aw for the enzymatic activity (~0.08). Thus, a compromise has
been found on the water content of the Sorbit DES, giving a good balance between viscosity
and water activity for an optimal substrate conversion. In the following section, we display
the structural elucidation of the product and the impact of the optimized combined factors
on our process.
2.5. Structural Elucidation Using Spectroscopic and Spectrometric Methods
Here, we report one of the most extensive structural characterizations of SL. 1H- and
13C-Nuclear Magnetic Resonance (NMR) Spectroscopy and Mass Spectrometry (MS) were
performed on the purified compound. Additional 1H-1H COSY and 1H-1H TOCSY, 1H-13C
HSQC and 1H-13C HMBC (Supplementary Materials, Figures S2–S5) combined with MS
results, confirmed that only one acyl group (laurate adduct) was bound to a primary
hydroxyl group of sorbitol. From the 1D- and 2D-NMR experiments, the chemical shifts
and their assignments are fully detailed in Table 3.
Table 3. 1H- and 13C-NMR chemical shifts of sorbitol-6-O-laurate (SL) with their molecular assignments.
Molecular Group 13C Shift (ppm) 1H Shift (ppm) Multiplicity Coupling (Hz)
Sorbitol
-C1H2-O- * 66.66 4.35, 4.18 dd, dd 3.0, 11.5, 6.3
-C2H- 70.69 3.91 m -
-C3H- 73.24 3.68 dd 5.28, 7.37
-C4H- 70.27 3.93 t 4.84
-C5H- 74.32 3.83 m -
OH-C6H2- 64.25 3.71 m -
Laurate
O=C1-OH * 174.46 - - -
-C2H2- * 34.64 2.33 t 7.6
-C3H2- 25.46 1.61 m -
-C4H2- 29.72 1.32 m -
-C5H2- 30.12 1.28 m -
-C6H2- 30.12 1.28 m -
-C7H2- 30.12 1.28 m -
-C8H2- 30.12 1.28 m -
-C9H2- 30.12 1.28 m -
-C10H2- 30.12 1.28 m -
-C11H2- 23.22 1.29 m -
-C12H3 14.35 0.88 t 7.00
* Acylation site; d = doublet; t = triplet; m = multiplet.
To determine which primary carbon of the meso- and the pseudo-asymmetric polyol is
bound to laurate, we measured a 1H-13C-HSQC with high resolution in the direct dimension
and no decoupling. Extraction of 1D slices along the respective carbon frequency allowed
estimation of vicinal 1H-1HJ couplings. Figure A1 shows the signals that belong to C4H
and C3H of the sorbitol. C4H is a triplet with coupling constants of 4.8 Hz, indicating that
both vicinal protons to this group are in cis position. C3H, on the other hand, displayed a
doublet of doublets with two different coupling constants of 5.3 Hz and 7.4 Hz; thus, here,
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the vicinal protons are different, best explained by one in cis and the other in trans position.
This proves that the laurate adduct is connected via the ester function to the C1H end of
the polyol.
MS was performed with ElectroSpray Ionization (ESI) (Supplementary Materials,
Figure S6). The spectrometric analysis of the synthesized SL is shown below in Table 4. In
the latter, 5 clear adducts of SL have been observed and correlated to possible adducts.
Table 4. Adducts determined from the observed m/z obtained via ElectroSpray Ionization-
Quadrupole (ESI-Q) experiment for the purified Sorbitol-6-O-Laurate (SL).
Observed m/z Value Corresponding Adduct Relative Abundance (%) *
329.232 [MSL + H]+-2H2O 7.27
347.243 [MSL + H]+-H2O 100
365.253 [MSL + H]+ 34.05
382.280 [MSL + NH4]+ 0.92
387.235 [MSL + Na]+ 18.57
* Calculated from the abundance of the ionic fragments on the y-axis, which was produced by in source fragmentation.
2.6. Optimized Tube Scale Production and Scalabilty
Combining the optimized factors allowed a product concentration of up to 50 g/L
of SL at the tube scale to be reached. Interestingly, to demonstrate the scalability of the
production in a batch STR, we ended up with a ~2-fold decrease of both titer and yield,
as shown in Table 5, suggesting that the reaction is sensitive to the effect of the reactor.
Presumably, the chosen parameters such as stirring speed and stirring did not match the
performance of orbital shaking and resulted in lower performance. Albeit we demonstrated
in the present work the scalability of our process. More investigation specific on this reactor
system that would focus on these parameters is needed.
Table 5. Impact of optimized factors on SL titer after 48 h in Sorbit DES with 5 wt.% water, using Novozym 435® at tube
and stirred-tank scales. Reaction conditions: 0.5 M vinyl laurate, 50 ◦C and 50 g/L enzyme formulation.
Scale/Stirring Titer (g/L) Yield *** (%)
Specific Reaction Velocity *** (µmol/h/g)
4 h 24 h 48 h
Tube/Orbital Shaking 50 ± 3 * 28 ± 2 * 151 ± 13 * 91 ± 4 * 54 ± 5 *
Stirred-Tank/3-bladed spiral propeller 25 ± 8 ** 14 ± 4 ** 134 ± 10 ** 40 ± 8 ** 29 ± 4 **
* n = 3, p-value < 0.05. ** n = 2, p-value < 0.1. *** Calculated from Equations (1) and (2), Section 4.9.
In Figure 5, we observe directly this blatant two-fold decrease in titer. However, it
is interesting to notice an equivalent titer in the early stage of the reaction being reached
in the STR and the orbitally shaken tubes with comparable initial velocities. After 24 h,
the difference in titer increases drastically while the specific productivity dropped in both
reactors with a 1:2.5 ratio between the two systems. Finally, at 48 h, reaction velocities
decreased again by roughly 2-fold, conserving a similar ratio as previous. Thus, it is
suspected that, comparatively, the enzyme was inhibited due to mass transfer limitations
in the STR.
We propose thereafter a discussion making a parallel between our results and pre-
existing ones in literature. Allowing us to give a broader aspect of the role of immobilized
enzymes, DESs and reactor technologies in sustainable processes such as, but not only
limited to, sugar ester synthesis.
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3. Discussion
3.1. Immobilized Lipases and Media Tailoring for Sustainable Biocatalyzed Esterifications
To enhance the performance of the biocatalyst, the immobilization of enzymes and,
more specifically, lipases are of high industrial interest, and it has become a requirement [29].
Indeed, it was shown in numerous reports that through, e.g., adsorption or covalent binding
with a solid carrier, some acyltransferases, such as the lipase B from Candida antarctica
(CaLB), could display improved activity, stability and reusability [30–32]. This phenomenon
can be understood inter alia as a gain of rigidity for the enzy e’s tertiary structure, which
li its protein unfo ding and thus denatura ion of th biocatalyst [33]. This is in practice
true in th case of the N vozym 435® f rmulation was recently qualified as the “perfect
immobilized biocatalyst” in a review from Ortiz et al. [34]. In parallel, the native CaLB
has been demonstrated to be among the most stable commerci lly avail le lipases [35,36].
By binding it to macroporous acrylic polymer resi (Lewatit VP OC 16,000), resul ing in
the now highly reported N vozym 435®, it i creased dras ically the performances of the
biocatalyst [37].
In the current work, it ight appear shocking th t we use 50 g/L of the enzyme
to reach the same alue in titer of product. At least on the tube scale, it is likely that,
in the case of Novozym 435®, the costs associated with the immobilization might be
fully compensated [38–48]. Indeed, the formulation can be recycled, using filtration,
for sometimes up to 10 cycles, as a report from Liu et al. demonstrates [49]. It is also
important to remember that in such a bead-adsorbed enzyme formulation, the non-catalytic
ballast of the carrier represents a tremendous portion of the biocatalyst’s mass (90 to
>99 wt.%) [37,50]. Thus, it is remarkable that in our work, the immobilized versions of
CaLB, such as Lipozyme 435® or Novozym 435®, rivalized with the buffered formulations
as they should normally contain a higher enzyme concentration.
Interestingly, CLEA CA was, in our case, comparable to the other CaLB formulations.
The Cross-Linked Enzyme Aggregates (CLEAs) first introduced by Sheldon et al. [51], but
also the Cross-Linked Enzyme Crystals (CLECs) [52], represent very interesting and more
elegant alternatives to the petrol-based polymer-carriers. CLEAs are a result of firsthand the
precipitation and physical aggregation of the enzymes, then secondhand the cross-linking
of these aggregates with a cross-linking agent, which can be typically glutaraldehyde. This
gives several advantages to CLEAs over their non-covalently immobilized analogues, such
as the quasi-nonexistent leaching of enzyme even under reportedly harsh conditions [53].
Due to the covalent inter-molecular binding, CLEAs and CLECs afford complete removal of
the carriers, thus resulting in carrier-free immobilized enzymes. However, they also present
limitations and challenges for their industrial-scale production, notably for the control
of the enzyme’s aggregation that can result in less active enzyme dimers [54]; thus, they
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are, to this day, rather rarely produced in bulk. On a side note, it is important to mention
that standard acrylic-bead-immobilized enzymes were easier to handle throughout the
tube-scale synthesis and downstream processing, than their CLEA analogues.
Herein, we reached an optimal titer after 48 h of reaction, which is like other reports
dealing with enzymatic production of sugar esters in DESs [11] but much shorter than
microbial fermentation to produce glycolipids. Indeed, as an example, to produce Man-
nosylerythritol Lipids (MELs), the average harvesting time is between 7 to 10 days for a
titer ranging from 15 g/L to 165 g/L, to obtain, in the case of the highest yields, complex
mixtures of MELs [55–58]. Additionally, and as we demonstrated, fewer factors must
be investigated when selectively producing tailor-made glycolipids using either free or
immobilized enzymes. On the other hand, microorganisms, such as yeasts or fungi, exhibit
much more complex behaviors that require acute control of the reaction conditions. In
this specific case, and despite MELs being well established on the market, mixtures of
products are often obtained, thus adding a degree of complexity to the DSP. Our process
using a “2-in-1” DES as media is rather more straightforward comparatively, but more
time and investigation are needed to overcome challenges to make it relevant for industrial
production. In regard to DSP, it has been shown in several studies that DESs can be recy-
cled as well [59–61]. In our case and for an efficient liquid–liquid extraction, the “2-in-1”
DES was first disrupted via aqueous solvation. Thus, it could be foreseeable that choline
chloride-rich wastes generated by such DES-mediated process could be re-valorized in feed
additives [62] or as agrochemical active ingredients [63]. Unlike organic solvents, DESs do
not have to undergo incineration; thus, their release in nature can be considered [64].
Analogously, a eutectic mixture using organic solvents (NaOH/DMSO/2M2B) was
investigated by Kim et al. for the synthesis of SL using lauric acid, reaching exceptionally
high yields (97%) using ~500 g/L of the enzyme [23]. Despite this remarkable achievement,
we propose, in contrast, a method using a deep eutectic system made of ubiquitous,
renewable and inexpensive compounds, such as choline chloride and sorbitol, using
10 times less biocatalyst. Concomitantly, they also reported an adverse effect of highly
viscous mixtures on the reaction, which correlates to the decreased titer we obtained when
the reaction’s water content was set to 2.5 wt.%. Overall, this might also explain our
comparatively inferior conversion yields, as it seems that deep eutectic systems present
challenges in terms of mass transfer limitations, meaning that our substrate hardly moves
to the enzyme’s active site. Zhao et al. reported a bisolvent system containing either ILs or
DESs in combination with 2M2B for glucose-based fatty acid esters production. Similar
factors were investigated and gave results equivalent to ours, such as an optimal enzyme
content of 20 g/L of Novozym 435® at 60 ◦C to reach 46 % conversion yield from the 0.3 M
of vinyl ester used [65].
The ever-growing knowledge on enzyme immobilization and media-tailoring tech-
nologies have shown to be crucial tools to reach sustainability in biocatalysis. They are also
of active interest for various industrial domains to develop greener and sustainable pro-
cesses [18,66–69]. Regarding this aim and as performance is of keen interest for industrial
application, reactor technology and scalability represent two important pillars as well.
3.2. Reactor Technology: Toward Scaling-Up Lipase-Catalyzed Reactions
The development of suitable reactors and technologies that support lipase-catalyzed
reactions is a topical subject for both academia and industry. Some parameters inherent
to reactors have been shown to be of high importance for the performance of the process.
For example, the speed of stirring can drastically influence the initial velocity of the
reaction and the conversion yield. This was clearly demonstrated in a research article
from Korupp et al. dealing with the enzymatic production of glycerol adipate using
Novozym 435® [70]. In the latter, they observed the highest conversion rates at 100 rpm.
The type of stirrer did not significantly influence the reaction; however, it was observed
that only a helicon ribbon stirrer gave uniform convection of both substrate and catalyst.
A similar observation was made in our case using a 3-bladed spiral propeller instead
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of a 4-bladed flat turbine (unpublished data), suggesting that homogeneity of highly
viscous mixtures can be reached optimally in an STR with stirrers that induce vertical
convection due to a rather axial flow. Indeed, studies from Wiemann et al. and Ansorge-
Schumacher et al. are suggesting that viscous mixtures requiring high energy input
might have a deleterious effect on the physical and mechanical properties of immobilized
formulations [71,72]. To corroborate these affirmations, a study from Keng et al. used
a Rushton turbine impeller, providing this time a radial flow that was seemingly more
adapted to the relatively lower viscosities of their n-hexane-based mixture [73]. In their
report dealing with the Lipozyme RM IM-catalyzed palm esters synthesis, it was clearly
concluded as well that the shear effect of high impeller speed on the enzyme particles
caused an adverse effect on reaction performances. Thus, potentially explaining our
significant loss of titer (~2-fold decrease) and lower reaction velocity when scaling up from
the tube to the STR (Table 5 and Figure 5). Altogether, it seems that a compromise needs
to be found on the stirrer type and its speed to conserve the integrity of the biocatalyst.
In this regard, more stable lipase formulations are commercialized to respond to this
problem. A good example is the recently co-developed and industrially produced CalB
immo Plus® from c-Lecta and Purolite companies (www.c-lecta.com, Leipzig, Germany/
www.purolite.com, King of Prussia, PA, USA). The highly hydrophobic carrier ECR1030M
(DVB/acrylate copolymer) exhibits enhanced mechanical stability and offers a controlled
size of spherical beads.
As a matter of fact, we mostly demonstrate what conditions were the most intrinsically
influential on the reaction, but further studies would be needed to optimize the process at
an even bigger scale. We essentially brought in the current work proof of the scalability of
our process and, more generally, the scalability of the DES-mediated biocatalysis, which is
scarcely represented in the literature [74]. Despite a lack of in-depth understanding of how
mechanistically DESs can activate and stabilize lipases, the room for improvement of this
topic toward industrial application is rather wide. However, we were able to demonstrate
that the preparative scale is reachable using a facile and straightforward method that
requires the minimum necessary equipment, as shown in the flowsheet of Figure 6. We
removed, therein, the need for continuous pH and gas composition assessment that are
standardly used in microbial fermentation, among other measurements that require probes
combined with their respective computer software.
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have proven to be promising alternatives to STRs and have shown good results when used
for immobilized enzymatic reactions [75]. Furthermore, their cooperation with Purolite
(www.purolite.com, King of Prussia, PA, USA) gave light to immobilized lipase cartridges,
theoretically forming a rotating packed bed reactor, which removes the need for filtration
during the DSP and simplifies the recovery of the biocatalyst. Remarkably, packed bed
reactors have also been combined with DESs for lipase-catalyzed esterifications. In a
relatively recent study from Guajardo et al., they managed the transition from a batch
to a fed-batch and continuous process, enhancing simultaneously conversion yield and
productivity, thus seemingly resolving the encountered issue of mass transfer limitations
and biocatalyst inhibition [76].
Recently as well, our research group published proof of a concept for the simultaneous
extraction of lipids from yeast and the subsequent ester production in a “2-in-1” Sorbit DES,
using microwave heating as an alternative to thermal heating [25]. This simplified and
fast method is only an example of the vast possibilities that DESs, immobilized enzymes
and innovative reactor systems can offer not only to the field of biocatalysis but also to
biotechnology in a broader scope.
4. Materials and Methods
4.1. Materials
Vinyl laurate was purchased from Tokyo Chemical Industry Co., Ltd. (TCI Eu-
rope, Zwijndrecht, Belgium). Lipase formulations: Novozym 435®, Lipozyme 435® and
Novozym NS 81356 were given by Novozymes (Bagsværd, Denmark). CalB Immo Plus®
was given by c-Lecta (Leipzig, Germany). CalA Immo 150, Lipase TL CLEA, Lipase CA
CLEA and all other chemicals were purchased from either Carl Roth GbmH & Co. KG
(Karlsruhe, Germany) or Sigma Aldrich Chemie GmbH (Taufkirchen, Germany) if not
stated otherwise. The other 9 lipase formulations were acquired in the Novozymes Lipase
Screening Kit purchased from Strem Chemicals (Newburyport, MA, USA).
4.2. DES Preparation and Standard SL Synthesis for Enzyme Formulation Screening
The sorbitol and choline chloride-based DES, dubbed “Sorbit DES”, was prepared and
validated according to the procedure described by Dai et al. and Hayyan et al. [77,78]. The
water content was varied (1.25, 2.5, 5, 7.5 and 10 wt.%) then controlled according to the
method described in Section 4.7.
In a 5 mL Eppendorf tube, were introduced subsequently 1.5 mL of warm Sorbit
DES, vinyl laurate (195 µL, 170 mg, 0.75 mmol, 0.5 M) and 30 mg of enzyme formulation
(20 g/L) (Table 1). The tubes containing the reaction mixture were agitated in a rotator
and vortex mixer (program U2) from neoLab (Heidelberg, Germany) at 90 rpm and 50 ◦C.
To get a triplicate for each measure, three tubes were collected for each time point at: 0.5,
4, 8, 24, 28, 32, 48, 72 and 96 h. The latter were then processed for further analysis as
described in Section 4.8, the conversion yields were calculated as the percentage of molar
ratio of sorbitol monoester produced to the total amount of vinyl laurate added to the
reaction system.
4.3. Enzyme Formulations Screening
To compare the lipase formulations (Table 1), an identical concentration of the latter
was used each time (20 g/L), and the same substrate concentration (0.5 M vinyl laurate) was
provided to the media at 50 ◦C. For this comparison, the reaction was stopped after 48 h.
4.4. Influence of Enzyme Concentration
In order to examine the optimal concentration of lipase formulation, different concen-
trations of Novozym 435® (10, 20, 30, 40, 50 and 60 g/L) were tested without varying any
other reaction parameter.
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4.5. Optimization of Vinyl Laurate Amount
To address the optimal vinyl fatty ester concentration for the reaction, different vinyl
laurate concentrations (0.25, 0.5, 0.75, 1 and 1.25 M) were tested. All other reaction condi-
tions were kept constant.
4.6. Water Content, Viscosity and Water Activity Analysis
The water content was assessed with Karl-Fischer titration using a TritoLine 7500 KF
trace from SI Analytics (Mainz, Germany) at 20 ◦C in combination with Aquastar Combi-
Coulomat fritless (Merck Millipore, Darmstadt, Germany) as analyte. Water standards of
0.1 and 1% in xylene from Merck Millipore (Darmstadt, Germany) were used to test the
titrator’s accuracy before the measurements.
The viscosity was measured at 50 ◦C with a viscosimeter MCR 501 using a CC10
concentric cylinder (Anton-Paar, Graz, Austria) with about 1 mL of liquid for each water
content for the Sorbit DES.
The water activity was measured at 50 ◦C with a LabMaster-aw neo Awmeter (No-
vasina, Lachen, Switzerland) using 3 mL of liquid for each water content for the Sorbit DES.
4.7. Scale-Up Procedure and Downstream Processing for Standard and Bulk SL Production
In a 2.5 L Minifors bioreactor (Infors HT, Bottmingen, Switzerland), 500 mL of warm
Sorbit DES were introduced, prepared as described in Section 4.2. The medium temperature
was first equilibrated to 50 ◦C then subsequently were introduced 25 g of Novozym 435®
(50 g/L) and vinyl laurate (65 mL, 56.62 g, 0.25 mol, 0.5 M). The reaction mixture was
stirred at 300 rpm with a single three-bladed spiral propeller (D = 54 × 12 mm) (Infors HT,
Bottmingen, Switzerland). After 48 h, the reaction was stopped, the media diluted with
500 mL of double-distilled water and filtrated through a Büchner funnel. In total, 200 mL
of brine were incorporated into the aqueous phase that was then extracted 6 times with a
1:1 volume ratio of ethyl acetate. The organic phases were gathered and chemically dried
over MgSO4 before being dry evaporated with a rotative evaporator.
For the purification of the SL standard that was used for the calibration curve, 2 g of
the crude paste was re-dissolved in chloroform to be adsorbed over 4 g of Celite 545 for
flash chromatography purification using the solid loading method. To purify this crude,
a Reveleris PREP purification system equipped with a 12 g Chromabond® Flash RS 15
Sphere SiOH column (Macherey-Nagel, Düren, Germany) was used. Elution solvents
were chloroform and methanol with a gradient such as 2nd solvent percentage started
at 0% for 1.5 min, 7% for 9.5 min, 15% for 3 min and finally 100% for 3 min. The second
fraction, containing SL, was collected at 7.5 min. The latter was dry evaporated on a rotary
evaporator for further use and analysis; ~0.75 g of dried, white powder (Supplementary
Materials, Figure S7).
For bulk production of SL, the entire crude (~25 g) was re-dissolved in the necessary
minimal volume of ethyl acetate (~400 mL) and washed with 1 × 400 mL of brine, and
then 3 × 400 mL of double-distilled water to remove unreacted sorbitol. The organic phase
was dried over MgSO4 and dry evaporated on a rotary evaporator; ~10 g of dried, white
powder (Supplementary Materials, Figure S8).
4.8. Sample Preparation and HPLC-ELSD Quantification Method
Tubes produced by the methods described in Sections 4.2–4.5 were prepared and
analyzed as follows. For extraction of the glycolipid and its quantification with HPLC-
ELSD, the following procedure was applied. First, 1 mL of double-distilled water was
added to the tube containing the reaction mixture and vortexed for 45 s. Then, 2.5 mL of
ethyl acetate was added to the warm solubilized DES; subsequently, the extraction took
place at 50 ◦C for 20 min with the use of the orbital shaker set on program U2 and 90 rpm
(neoLab, Heidelberg, Germany). Then, 1 mL of the upper phase was aliquoted and dried
on a centrifugal evaporator in order to be resolubilized in 1 mL of chloroform/methanol
(75:25 v/v), and 100 µL was placed into an HPLC vial for further quantification.
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The method described by Hollenbach et al. [28,79] was used with slight modifications
as follows. Kinetex EVO C18 (2.6 mm, 250 mm × 4.6 mm) column from Phenomenex
(Aschaffenburg, Germany) with an accompanying guard column (4 mm × 3.0 mm ID) of
the same phase, using an Agilent 1260 series liquid chromatograph (Waldbronn, Germany)
equipped with a quaternary pump, an autosampler and a column oven. An evaporative
light scattering detector (ELSD) from BÜCHI Labortechnik (Essen, Germany) was used
for detection. The mobile phase, solvent A, was water and solvent B was acetonitrile. The
flow rate was 1 mL/min, and a gradient was used for separation of product and substrates:
starting from 40% A–60% B, then 0–10 min a linear gradient up to 35% A–65% B, followed
by another linear gradient from 10 to 15 min up to 25% A–75% B. This gradient was held
for 5 min, followed by a reconditioning step of the column with 40% A–60% B for 5 min.
The injection volume was set to 10 µL. The column was operated at 50 ◦C. The detector was
operated at 38 ◦C with a gas flow (air) of 1.5 mL/min. The gain was set to 1. The retention






Specific reaction velocity [µmol/h/g] =
nSL [µmol]
mBiocatalyst [g]× time [h] (2)
n: number of moles.
m: mass.
4.9. Spectroscopic and Spectrometric Methods for Structural Elucidation of SL
For nuclear magnetic resonance (NMR) spectroscopy, 10 mg of purified SL was dis-
solved in 0.6 mL CD2Cl2/d6-acetone (4:1, by vol.). Then, 1D 1H-NMR spectroscopy
and 2D 1H-1H correlation spectroscopy (COSY), 1H-1H total correlation spectroscopy
(TOCSY), 1H-13C heteronuclear single-quantum correlation (HSQC) spectroscopy and
1H-13C-heteronuclear multiple-bond correlation (HMBC) spectroscopy were performed
on a Bruker AVANCE III 600 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany)
equipped with a TCI cryoprobe at a temperature of 27 ◦C. Spectra were processed and
analyzed using Topspin 4.0.1 (Bruker BioSpin) and MestReNova 14.2.0 (Mestrelab Research
S.L., Santiago de Compostela, Spain). Chemical shifts were referenced to the 1H and
13C-resonance of tetramethylsilane (TMS).
The mass spectrometry (MS) for mass identifications was performed with electrospray
ionization (ESI) on a quadrupole Q Exactive Plus (ThermoFisher Scientific GmbH, Kan-
del, Germany) and recorded in positive mode, and raw spectrometric data were treated
using MestReNova Suite 2020 (version 14.2.0) (Mestrelab Research S.L., Santiago de Com-
postela, Spain).
4.10. Data Treatment and Statistical Analysis
OriginPro software 9.7 (version 2020) (OriginLab Corporation, Northampton, MA,
USA) was used for raw data treatment and statistical analysis. Results are presented as
mean ± standard deviation (n = 3). Statistical analysis was performed by one-way ANOVA
and Tukey test, and the results were considered significant if the p-value was <0.05 if not
stated otherwise.
5. Conclusions
In this work, we presented the screening of 16 commercially available lipase formu-
lations for the DES-mediated and lipase-catalyzed production of glycolipid sorbitol-6-O-
laurate. We determined the influence of several factors, such as time of reaction, enzyme
dosage, substrate concentration and water content, when using Novozym 435® as bio-
catalyst owing to our newly HPLC-ELSD quantification method. We, therein, elucidated
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and identified, with complete spectroscopy and spectrometry analysis, the structure of the
targeted compound. To finalize our report, we brought evidence of the possible scalability
of the process and its importance for sustainable biocatalysis by highlighting analogous
knowledge and facts from the literature. Overall, we show that despite many challenges
and limitations, DESs demonstrate factually potential for mediating bioprocesses. Thus,
it is foreseeable that more and more concrete applications will emerge concerning this
specific topic.
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